Mackenzie Financial
LXRX icon

Mackenzie Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

Mackenzie Financial’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31M Buy
963,354
+190,677
+25% +$371K ﹤0.01% 1013
2026
Q1 		$1.21M Buy
+772,677
New +$1.12M ﹤0.01% 1047
2020
Q4 		– Sell
-13,500
Closed -$19K – 1074
2020
Q3 		$19K Hold
13,500
– – ﹤0.01% 986
2020
Q2 		$27K Buy
13,500
+3,200
+31% +$6.27K ﹤0.01% 993
2020
Q1 		$20K Buy
+10,300
New +$30.7K ﹤0.01% 1057

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mackenzie Financial's LXRX Position: Q2 2026 in Review

Mackenzie Financial increased its Lexicon Pharmaceuticals (LXRX) stake by 25% in Q2 2026, buying an estimated $371K and bringing the position to 963,354 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Mackenzie Financial first reported a position in LXRX in Q1 2020 and has held it in 5 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Mackenzie Financial held 963,354 shares of Lexicon Pharmaceuticals worth $2.31M as of Q2 2026.
  • Mackenzie Financial bought 190,677 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $371K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1013 holding.
  • Mackenzie Financial first reported a position in Lexicon Pharmaceuticals in Q1 2020 and has held it in 5 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.